Feinstein Institute and Notre Dame to Collaborate on Biomedical Research

Manhasset, NY – The Feinstein Institute for Medical Research and the University of Notre Dame today announced a collaboration on biomedical research projects involving sepsis and other diseases, student training, joint conferences and other forms of academic exchange.

“Each of our institutions brings with it a unique set of research skills and capabilities,” said Kevin J. Tracey, MD, president of the Feinstein Institute. “By working together, we will be able to make real advances in addressing a number of serious health challenges.”

“Being able to work closely with the world-class clinical researchers in their specialties at the Feinstein Institute will allow our analytical scientists and engineers to continue to be a powerful means for good in the world by solving problems of immediate interest to physicians and hospitals,” said Robert Bernhard, PhD, vice president for research at the University of Notre Dame. “We are grateful for the opportunity of this partnership and look forward to the fruitful results that this collaboration will bring.”

Under the agreement, the two institutions will collaborate on research and joint publications of results, share scientific materials and publications, offer students an exchange program so they can experience research in another lab, and cooperate in the commercialization of inventions or intellectual properties. Early targets of the collaboration include sepsis, the leading cause of death from infection in the world and the costliest condition for US hospitals, bioelectronic medicine, devices that stimulate nerves to treat disease, and the development of tools and methods for exosome biology, which has broad implications for diseases that affect the brain, like Alzheimer’s disease and Parkinson’s disease.

The Feinstein Institute and University of Notre Dame are also partners in the Cleveland Clinic Healthcare Innovation Alliance, a national network through which healthcare organizations and scientists benefit patients by combining efforts in research, clinical investigation, and technology development and commercialization.

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson’s disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit www.FeinsteinInstitute.org.

Media Contact:
Emily Ng
(516) 562-2670